Bio Developments

Italian drugmaker commits to ADC development

Menarini forms ADC manufacturing deal with OBT

By Gareth Macdonald

Menarini has committed millions of euros to an antibody drug conjugate (ADC) clinical development and manufacturing pact with Oxford BioTerapeutics (OBT). 

Manufacturing deals for DSM, Lonza, ARk and AMRI

News from Lonza, DSM, Ark and AMRI

Outsourcing-pharma.com presents a roundup of contract manufacturing news with deals for Lonza, DSM and Ark Therapeutics and an expanded agreement with Shire for AMRI.  

Follow us

Webinars